P345 BMI (Z-scores) in children with cystic fibrosis improved despite comparable energy and nutritional intake following the introduction of elexacaftor/tezacaftor/ivacaftor therapy
А. М. Орел(University of Ljubljana), Jasna Rodman Berlot(Ljubljana University Medical Centre), Uroš Krivec(University of Ljubljana), Jernej Brecelj(University of Ljubljana), A. Praprotnik Novak(Ljubljana University Medical Centre)
Cited by 1
Related Papers
Genotype correlates with the natural history of severe bile salt export pump deficiency
|Journal of Hepatology|2020|133
Characteristics of Gastroesophageal Reflux and Potential Risk of Gastric Content Aspiration in Children With Cystic Fibrosis
|Journal of Pediatric Gastroenterology and Nutrition|2010|90
High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease
|Autoimmunity|2016|61
Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency
|Hepatology|2021|56
Success and safety of high infliximab trough levels in inflammatory bowel disease
|Scandinavian Journal of Gastroenterology|2018|46